Effects of lorazepam upon recollective experience in recognition memory
- PMID: 7831435
- DOI: 10.1007/BF02251297
Effects of lorazepam upon recollective experience in recognition memory
Abstract
The effects of lorazepam (2 mg) and placebo upon recognition memory with and without conscious recollection were assessed in a cross-over study with normal volunteers. When recognising a word from study lists presented before and 1, 3 and 5 h after drug administration, subjects were required to indicate whether they could consciously recollect the word's prior occurrence or recognised it on the basis of "knowing"; in the absence of conscious recollection. Lorazepam only impaired word recognition which was accompanied by conscious recollection, and further, the level of this impairment correlated significantly with each of three different indices of subjects' arousal at the time of presentation of each list. Recognition in the absence of conscious recollection was not impaired but somewhat heightened by lorazepam, and these effects did not significantly relate to any index of arousal. These findings are interpreted as providing further support for the notion that recognition entails two distinct components, one based on contextual and associative information and related to conscious recollection, the other possibly based on a "traceless" perceptual or semantic memory system and related to feelings of knowing in the absence of conscious recollection. Implications are drawn for a contextual-encoding/retrieval account of lorazepam-induced amnesia.
Similar articles
-
Attention and recollective experience in recognition memory.Mem Cognit. 1990 Nov;18(6):579-83. doi: 10.3758/bf03197100. Mem Cognit. 1990. PMID: 2266859
-
Recollective experience in word and nonword recognition.Mem Cognit. 1990 Jan;18(1):23-30. doi: 10.3758/bf03202642. Mem Cognit. 1990. PMID: 2314224
-
Lorazepam, sedation, and conscious recollection: a dose-response study with healthy volunteers.Int Clin Psychopharmacol. 2002 Jan;17(1):19-26. doi: 10.1097/00004850-200201000-00003. Int Clin Psychopharmacol. 2002. PMID: 11800502 Clinical Trial.
-
Flumazenil: US clinical pharmacology studies.Eur J Anaesthesiol Suppl. 1988;2:81-95. Eur J Anaesthesiol Suppl. 1988. PMID: 2842144 Review.
-
Subjective experience of episodic memory and metacognition: a neurodevelopmental approach.Front Behav Neurosci. 2013 Dec 25;7:212. doi: 10.3389/fnbeh.2013.00212. Front Behav Neurosci. 2013. PMID: 24399944 Free PMC article. Review.
Cited by
-
The role of decision processes in remembering and knowing.Mem Cognit. 1996 Jul;24(4):523-33. doi: 10.3758/bf03200940. Mem Cognit. 1996. PMID: 8757500
-
The impact of post-encoding alcohol consumption on episodic memory recall and remember-know responses in heavy drinkers.Front Psychol. 2023 Mar 7;14:1007477. doi: 10.3389/fpsyg.2023.1007477. eCollection 2023. Front Psychol. 2023. PMID: 36960000 Free PMC article.
-
Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.Psychopharmacology (Berl). 1995 Sep;121(2):267-78. doi: 10.1007/BF02245638. Psychopharmacology (Berl). 1995. PMID: 8545533 Clinical Trial.
-
Effects of the amnesic drug lorazepam on complete and partial information retrieval and monitoring accuracy.Psychopharmacology (Berl). 2006 Nov;188(4):472-81. doi: 10.1007/s00213-006-0492-2. Epub 2006 Aug 17. Psychopharmacology (Berl). 2006. PMID: 16915380 Clinical Trial.
-
Individual Differences in Working Memory Capacity Predict Topiramate-Related Cognitive Deficits.J Clin Psychopharmacol. 2018 Oct;38(5):481-488. doi: 10.1097/JCP.0000000000000949. J Clin Psychopharmacol. 2018. PMID: 30124584 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical